{"id":5391,"date":"2022-09-09T15:22:00","date_gmt":"2022-09-09T13:22:00","guid":{"rendered":"https:\/\/plnt.nl\/?post_type=nieuwsberichten&#038;p=5391"},"modified":"2023-03-06T16:04:51","modified_gmt":"2023-03-06T15:04:51","slug":"iprotics-wins-the-venture-challenge-spring-2022","status":"publish","type":"nieuwsberichten","link":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/","title":{"rendered":"iProtics wins the Venture Challenge Spring 2022"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"5391\" class=\"elementor elementor-5391\" data-elementor-post-type=\"nieuwsberichten\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9da3498 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9da3498\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fa9c66e\" data-id=\"fa9c66e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d0ce32a elementor-widget elementor-widget-text-editor\" data-id=\"d0ce32a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em>The winner of the Venture Challenge was announced today at the\u00a0<a href=\"https:\/\/www.hollandbio.nl\/event\/dutch-biotech-event-2022\/\" target=\"_blank\" rel=\"noopener\">Dutch Biotech Event<\/a>. The proud winner of the 2022 spring edition is\u00a0<a href=\"https:\/\/www.lifesciencesatwork.nl\/startups\/iprotics\" target=\"_blank\" rel=\"noopener\">iProtics<\/a>!\u00a0The innovative startup iProtics has developed\u00a0specific proteasome inhibitors that potentially treat multiple myeloma (MM)\u00a0without the side-effects known from traditional proteasome inhibitors.<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e935b16 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e935b16\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f60fc79\" data-id=\"f60fc79\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-af63506 elementor-widget elementor-widget-text-editor\" data-id=\"af63506\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>According to the jury, composed of Carine van den Brink, Geert-Jan Mulder, Olga Liska, Daniela Begolo and Jan-Frens van Giessel,\u00a0iProtics is addressing a real need as experienced by patients suffering from multiple myeloma (MM). They have a clear value proposition on which they can expand in the future. iProtics has developed a superior proteasome inhibitor compared to existing therapies. It is their aim to develop these leads to become the first-in-line treatment for MM patients. The unique compounds, for which IP protection is sought for and to which iProtics will obtain an exclusive license, inhibit with exquisite selectivity immunoproteasomes while leaving constitutive proteasomes intact. MM cells uniquely rely on immunoproteasomes for protein turnover and survival, whereas healthy tissue express constitutive proteasomes mostly. They have proof of concept in cell lines and primary patient tumour cells showing that their compounds efficiently and at low concentrations kill MM cells, but not healthy cells. iProtics leads are expected to give less side effects and a considerably enlarged therapeutic window, and potentially increase patient lifespan and quality of life.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0271fd2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0271fd2\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-daeaa2e\" data-id=\"daeaa2e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b44f6c6 elementor-testimonial--skin-default elementor-testimonial--layout-image_inline elementor-testimonial--align-center elementor-arrows-yes elementor-pagination-type-bullets elementor-widget elementor-widget-testimonial-carousel\" data-id=\"b44f6c6\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;show_arrows&quot;:&quot;yes&quot;,&quot;pagination&quot;:&quot;bullets&quot;,&quot;speed&quot;:500,&quot;autoplay&quot;:&quot;yes&quot;,&quot;autoplay_speed&quot;:5000,&quot;loop&quot;:&quot;yes&quot;,&quot;pause_on_hover&quot;:&quot;yes&quot;,&quot;pause_on_interaction&quot;:&quot;yes&quot;,&quot;space_between&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:10,&quot;sizes&quot;:[]},&quot;space_between_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:10,&quot;sizes&quot;:[]},&quot;space_between_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:10,&quot;sizes&quot;:[]}}\" data-widget_type=\"testimonial-carousel.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-swiper\">\n\t\t\t\t\t<div class=\"elementor-main-swiper swiper\" role=\"region\" aria-roledescription=\"carousel\" aria-label=\"Slides\">\n\t\t\t\t<div class=\"swiper-wrapper\">\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"swiper-slide\" role=\"group\" aria-roledescription=\"slide\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-testimonial\">\n\t\t\t\t\t\t\t<div class=\"elementor-testimonial__content\">\n\t\t\t\t\t<div class=\"elementor-testimonial__text\">\n\t\t\t\t\t\t\u2018We had a great idea but we did not know where to go with it. However, thanks to the Venture Challenge, we are now poised to start a company to develop our compounds and take them to the clinic\u2019\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"elementor-testimonial__footer\">\n\t\t\t\t\t\t\t\t<cite class=\"elementor-testimonial__cite\"><span class=\"elementor-testimonial__name\">Elmer Maurits<\/span><span class=\"elementor-testimonial__title\">Founder of iProtics<\/span><\/cite>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a6d1756 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a6d1756\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-20b9172\" data-id=\"20b9172\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-192f10e elementor-widget elementor-widget-button\" data-id=\"192f10e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Read the full article here<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bbcde8a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bbcde8a\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2fc4d24\" data-id=\"2fc4d24\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-85d37e8 elementor-widget elementor-widget-text-editor\" data-id=\"85d37e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em>The\u00a0<a class=\"external\" href=\"https:\/\/www.nwo.nl\/en\/researchprogrammes\/venture-challenge\" target=\"_blank\" rel=\"noopener\">NWO Venture Challenge<\/a>\u00a0helps starting entrepreneurs in the life sciences to bring their service or product to the market. In a programme of approximately ten weeks, starters receive support in setting up a company and develop their idea into a solid business case. Examples from the past show that the time-to-market can be shortened through the Venture Challenge. The Venture Challenge has two rounds per year (spring and fall edition). Winners receive\u00a0\u20ac25.000 prize money\u00a0to invest in their\u00a0growth.<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"featured_media":5583,"template":"","class_list":["post-5391","nieuwsberichten","type-nieuwsberichten","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>iProtics wins the Venture Challenge Spring 2022 - PLNT<\/title>\n<meta name=\"description\" content=\"iProtics announced the winner of the Venture Challenge 2022 Spring edition.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iProtics wins the Venture Challenge Spring 2022 - PLNT\" \/>\n<meta property=\"og:description\" content=\"iProtics announced the winner of the Venture Challenge 2022 Spring edition.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"PLNT\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-06T15:04:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/02\/Nieuws-header-website-PLNT.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"532\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@PLNT_Leiden\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/\",\"url\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/\",\"name\":\"iProtics wins the Venture Challenge Spring 2022 - PLNT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Nieuws-header-website-PLNT.png\",\"datePublished\":\"2022-09-09T13:22:00+00:00\",\"dateModified\":\"2023-03-06T15:04:51+00:00\",\"description\":\"iProtics announced the winner of the Venture Challenge 2022 Spring edition.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Nieuws-header-website-PLNT.png\",\"contentUrl\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Nieuws-header-website-PLNT.png\",\"width\":1920,\"height\":532},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/iprotics-wins-the-venture-challenge-spring-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/plnt.nl\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iProtics wins the Venture Challenge Spring 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/plnt.nl\\\/en\\\/\",\"name\":\"PLNT\",\"description\":\"Where innovation meets entrepreneurship.\",\"publisher\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/plnt.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#organization\",\"name\":\"PLNT\",\"url\":\"https:\\\/\\\/plnt.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/PLNT-Logo-Liggend-Zwart.png\",\"contentUrl\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/PLNT-Logo-Liggend-Zwart.png\",\"width\":6689,\"height\":4405,\"caption\":\"PLNT\"},\"image\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/PLNT_Leiden\",\"https:\\\/\\\/www.instagram.com\\\/plntleiden\\\/?hl=nl\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/plnt-leiden\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iProtics wins the Venture Challenge Spring 2022 - PLNT","description":"iProtics announced the winner of the Venture Challenge 2022 Spring edition.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/","og_locale":"en_US","og_type":"article","og_title":"iProtics wins the Venture Challenge Spring 2022 - PLNT","og_description":"iProtics announced the winner of the Venture Challenge 2022 Spring edition.","og_url":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/","og_site_name":"PLNT","article_modified_time":"2023-03-06T15:04:51+00:00","og_image":[{"width":1920,"height":532,"url":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/02\/Nieuws-header-website-PLNT.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@PLNT_Leiden","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/","url":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/","name":"iProtics wins the Venture Challenge Spring 2022 - PLNT","isPartOf":{"@id":"https:\/\/plnt.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/#primaryimage"},"image":{"@id":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/02\/Nieuws-header-website-PLNT.png","datePublished":"2022-09-09T13:22:00+00:00","dateModified":"2023-03-06T15:04:51+00:00","description":"iProtics announced the winner of the Venture Challenge 2022 Spring edition.","breadcrumb":{"@id":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/#primaryimage","url":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/02\/Nieuws-header-website-PLNT.png","contentUrl":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/02\/Nieuws-header-website-PLNT.png","width":1920,"height":532},{"@type":"BreadcrumbList","@id":"https:\/\/plnt.nl\/en\/news\/iprotics-wins-the-venture-challenge-spring-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/plnt.nl\/en\/home\/"},{"@type":"ListItem","position":2,"name":"iProtics wins the Venture Challenge Spring 2022"}]},{"@type":"WebSite","@id":"https:\/\/plnt.nl\/en\/#website","url":"https:\/\/plnt.nl\/en\/","name":"PLNT","description":"Where innovation meets entrepreneurship.","publisher":{"@id":"https:\/\/plnt.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/plnt.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/plnt.nl\/en\/#organization","name":"PLNT","url":"https:\/\/plnt.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/plnt.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/01\/PLNT-Logo-Liggend-Zwart.png","contentUrl":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/01\/PLNT-Logo-Liggend-Zwart.png","width":6689,"height":4405,"caption":"PLNT"},"image":{"@id":"https:\/\/plnt.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/PLNT_Leiden","https:\/\/www.instagram.com\/plntleiden\/?hl=nl","https:\/\/www.linkedin.com\/company\/plnt-leiden\/"]}]}},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten\/5391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten"}],"about":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/types\/nieuwsberichten"}],"version-history":[{"count":6,"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten\/5391\/revisions"}],"predecessor-version":[{"id":6632,"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten\/5391\/revisions\/6632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/media\/5583"}],"wp:attachment":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/media?parent=5391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}